[PDF] snmjournals.org

Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post-hoc analysis of the …

T Carlier, C Ansquer, A Rauscher… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Introduction: Pretargeting parameters for use the anti-CEA (carcinoembryonic antigen)
bispecific monoclonal antibody TF2 and the 68 Ga-labeled IMP288 peptide (68 Ga-IMP288) …
Save Cite Related articles
[PDF] snmjournals.orgFree from Publisher

Anti-CEA pretargeted immuno-PET shows higher sensitivity than DOPA PET/CT in detecting relapsing metastatic medullary thyroid carcinoma: post hoc analysis of the …

C Bodet-Milin, A Faivre-Chauvet, T Carlier… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Pretargeting parameters for the use of anti–carcinoembryonic antigen (CEA) bispecific
monoclonal antibody TF2 and the 68Ga-labeled IMP288 peptide for immuno-PET have …
Save Cite Cited by 16 Related articles All 9 versions
[PDF] snmjournals.orgFree from Publisher

Immuno-PET using anti-CEA bispecific antibody and 68Ga-labeled peptide in metastatic medullary thyroid carcinoma: clinical optimization of the pretargeting …

A Faivre-Chauvet, T Carlier, A Rauscher… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Earlier clinical studies reported a high sensitivity of pretargeted immunoscintigraphy using
murine or chimeric anti-carcinoembryonic antigen (CEA) bispecific antibody (BsMAb) and …
Save Cite Cited by 4 Related articles All 2 versions
[PDF] snmjournals.orgFree from Publisher

Immuno-PET using anticarcinoembryonic antigen bispecific antibody and 68Ga-labeled peptide in metastatic medullary thyroid carcinoma: clinical optimization of the …

C Bodet-Milin, A Faivre-Chauvet, T Carlier… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Earlier clinical studies reported a high sensitivity of pretargeted immunoscintigraphy using
murine or chimeric anticarcinoembryonic antigen (CEA) bispecific antibody (BsMAb) and …
Save Cite Cited by 69 Related articles All 9 versions
[HTML] frontiersin.org

[HTML][HTML] Clinical results in medullary thyroid carcinoma suggest high potential of pretargeted immuno-PET for tumor imaging and theranostic approaches

C Bodet-Milin, C Bailly, Y Touchefeu, E Frampas… - Frontiers in …, 2019 - frontiersin.org
Monoclonal antibody (mAb)-based therapies have experienced considerable growth in
cancer management. When labeled with radionuclides, mAbs also represent promising …
Save Cite Cited by 23 Related articles All 8 versions Cached
[HTML] oup.com

Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary …

A Oudoux, PY Salaun, C Bournaud… - The Journal of …, 2007 - academic.oup.com
Context: Patients with progressive medullary thyroid carcinoma (MTC) undergo multiple
imaging procedures for diagnosis of relapse and staging. Objective: Our objective was to …
Save Cite Cited by 113 Related articles All 8 versions

Positron emission tomography with F-18-fluorodeoxyglucose (PET-FDG) in patients with rapidly progressing medullary thyroid carcinoma (MTC)

A Oudoux, PY Salaun, C Ansquer, S Bardet, A Perrin… - 2006 - Soc Nuclear Med
1298 Objectives: This study evaluated prospectively the sensitivity of FDG-PET for staging of
progressing MTC patients (pts) enrolled in a phase-II pretargeting CEA radioimmunotherapy …
Save Cite Cited by 1 Related articles
[HTML] osti.gov

18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma

PY Salaun, L Campion, C Ansquer, E Frampas… - European journal of …, 2014 - Springer
Purpose PET is a powerful tool for assessing targeted therapy. Since 18 F-FDG shows a
potential prognostic value in medullary thyroid carcinoma (MTC), this study evaluated 18 F …
Save Cite Cited by 11 Related articles All 13 versions

Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer

M Tuncel, S Kılıçkap, N Süslü - Annals of nuclear medicine, 2020 - Springer
Purpose Medullary thyroid cancer (MTC) arises from neuroendocrine C cells of the thyroid.
There is no single diagnostic imaging method that can reveal all MTC recurrences or …
Save Cite Cited by 25 Related articles All 4 versions

68Ga-DOTATATE-PET shows promise for diagnosis of recurrent or persistent medullary thyroid cancer: A systematic review

C Pajak, L Cadili, K Nabata, SM Wiseman - The American Journal of …, 2022 - Elsevier
Abstract Background Many patients with Medullary Thyroid Cancer (MTC) will have
persistent or recurrent disease after surgery requiring lifelong surveillance with imaging and …
Save Cite Cited by 14 Related articles All 4 versions